| Product Name | MF | CAS | Details |
|---|
| FWM-3 | C16H16N6O2S | 714923-33-8 | Details |
| α-Glucosidase-IN-16 | C22H18FNS | 1606142-34-0 | Details |
| MRGPRX4 modulator-2 | C15H9ClF4O3 | 2492595-24-9 | Details |
| PAK4-IN-2 | C18H21ClN6 | 2488706-33-6 | Details |
| LDHA/PDKs-IN-1 | C19H21FN2O4 | 2490699-40-4 | Details |
| AChE/BChE-IN-9 | C20H19N3O4 | 2761542-55-4 | Details |
| Topoisomerase II inhibitor 3 | C18H20N4O4 | 99140-25-7 | Details |
| Antileishmanial agent-3 | C14H13ClN6O4 | 2755930-28-8 | Details |
| Antiparasitic agent-2 | C20H17N3O3 | 2494277-80-2 | Details |
| Anticancer agent 74 | C25H21NO | 2242503-82-6 | Details |
| PDE11-IN-1 | C16H10ClN3O3S | 522652-41-1 | Details |
| hCAIX/XII-IN-4 | C20H16N2O5 | 1119200-33-7 | Details |
| mGluR2 modulator 4 | C18H18BrN3 | 2582758-47-0 | Details |
| HIF-1α-IN-2 | C21H19N3OS | 2762315-06-8 | Details |
| ZLD2218 | C22H18N4O | 2713974-32-2 | Details |
| α-Glucosidase-IN-20 | C23H21NOS | 420809-56-9 | Details |
| Cdc7-IN-13 | C18H20N4O2S | 2764866-23-9 | Details |
| HFI-419 | C19H18N2O5 | 1110650-72-0 | Details |
| APX2039 | C20H15FN4O2 | 2342606-49-7 | Details |
| TRK-IN-15 | C19H20FN5O | 1365213-20-2 | Details |
| Cdc7-IN-19 | C19H21N5O2 | 2606780-39-4 | Details |
| COX-1/2-IN-1 | C15H10BrClN2O | 2358849-47-3 | Details |
| MAT2A-IN-5 | C17H12ClF3N2O | 2756458-55-4 | Details |
| Carpro-AM1 | C21H18ClN3O | 2499489-76-6 | Details |
| Antiparasitic agent-7 | C18H15N3O5 | 2253996-75-5 | Details |
| DC-CPin7 | C19H22N2O5 | 893781-17-4 | Details |
| hCAIX-IN-6 | C18H12N2O4S | 2451479-86-8 | Details |
| Antiparasitic agent-8 | C17H22FN3O4 | 2538594-33-9 | Details |
| Antitumor agent-57 | C20H15NO5 | 2432823-48-6 | Details |
| PARP1-IN-9 | C18H21N3O5 | 2494000-71-2 | Details |
| Xanthine oxidoreductase-IN-2 | C21H19N3O2 | 2396612-45-4 | Details |
| LSD1-IN-14 | C21H24FN5 | 2698340-11-1 | Details |
| EGFR-IN-64 | C20H21N3O3 | 2416924-93-9 | Details |
| Plasma kallikrein-IN-3 | C20H23N5O2 | 1357950-47-0 | Details |
| Z164597606 | C20H19N3O4 | 1050587-57-9 | Details |
| BET-IN-7 | C18H12ClN3OS | 303985-05-9 | Details |
| hCAI/II-IN-2 | C12H12N4O5S2 | 2480283-75-6 | Details |
| EGFR-IN-68 | C24H22N2O | 2416925-03-4 | Details |
| HIF-2α-IN-6 | C15H13F4NO3S | 2755401-07-9 | Details |
| p53 Activator 2 | C20H21N5O2 | 2338764-89-7 | Details |
| CXCR2 antagonist 3 | C17H15FN2O4S | 2647464-92-2 | Details |
| IDO1/TDO-IN-1 | C21H16O6 | 2379527-72-5 | Details |
| MIF-IN-5 | C18H14FN5O2 | 2582755-31-3 | Details |
| (S)-Baxdrostat | C22H25N3O2 | 1428652-16-7 | Details |
| Antituberculosis agent-1 | C21H21NO4 | 2411740-98-0 | Details |
| JAK-2/3-IN-2 | C19H19ClN2OS | 2170398-48-6 | Details |
| MRGPRX4 modulator-1 | C16H13ClF3NO3 | 2492596-61-7 | Details |
| Anabolic agent-1 | C15H22N2O6S | 2439179-74-3 | Details |
| Cdc7-IN-8 | C19H21N5O2 | 2606780-38-3 | Details |
| Aβ-IN-5 | C21H20N2O3 | 2417977-65-0 | Details |
| Stemphyperylenol | C20H16O6 | 102694-33-7 | Details |
| ARN25068 | C19H18N6S | 2649882-80-2 | Details |
| COX-2-IN-19 | C18H18N4O2S | 2497530-12-6 | Details |
| Mt KARI-IN-4 | C13H8FN5O3S2 | 2413974-53-3 | Details |
| Irdabisant hydrochloride | C18H24ClN3O2 | 1005398-61-7 | Details |
| Neuraminidase-IN-5 | C19H11NO7 | 2473524-63-7 | Details |
| TNIK-IN-4 | C20H16FN3O3 | 2754266-04-9 | Details |
| PDE4-IN-11 | C21H19FN2O2 | 524734-30-3 | Details |
| RBM10-8 | C17H36NO5P | 2407372-42-1 | Details |
| FAK-IN-8 | C15H9Cl2N3O2S | 1374959-91-7 | Details |
| Tubulin inhibitor 12 | C24H20N2O | 92575-00-3 | Details |
| COX-2/5-LOX-IN-3 | C17H16ClN3O2S | 2481484-51-7 | Details |
| 5-HT6/5-HT2A receptor ligand-2 | C20H18FN3O2 | 2411088-16-7 | Details |
| Anti-inflammatory agent 17 | C20H23NO5 | 2763226-84-0 | Details |
| MAO-B-IN-12 | C22H30O4 | 2394733-97-0 | Details |
| F-17 | C17H15BrO4 | 1572464-22-2 | Details |
| NAT2-IN-1 | C19H20N4O3 | 856005-97-5 | Details |
| CO delivery molecule 1 | C23H21NO3 | 1972616-04-8 | Details |
| hCAXII-IN-1 | C20H17NO5 | 2451479-66-4 | Details |
| CA224 | C24H22N2O | 883561-04-4 | Details |
| hDHODH-IN-9 | C21H21NO4 | 133676-47-8 | Details |
| CBR-6672 | C17H20FN3O2S | 2225885-40-3 | Details |
| Anticancer agent 47 | C19H14N2O4S | 2461795-23-1 | Details |
| Antibacterial agent 94 | C21H21FO4 | 1666134-58-2 | Details |
| Colletotrichalactones A | C20H20O6 | 2751633-79-9 | Details |
| Orbofiban | C17H23N5O4 | 163250-90-6 | Details |
| P163-0892 | C19H20N2O3S | 1574576-45-6 | Details |
| CDK1/Cyc B-IN-1 | C14H12ClN3O2S2 | 2459916-56-2 | Details |
| MmpL3-IN-1 | C20H21F2N3O | 2290534-93-7 | Details |
| BChE-IN-13 | C24H28N2O | 2700896-73-5 | Details |
| Antibacterial agent 96 | C18H15Cl2NO2 | 2413006-62-7 | Details |
| Protein kinase D inhibitor 1 | C19H21N7 | 2489320-03-6 | Details |
| R-PSOP | C20H22N4O2 | 1185189-97-2 | Details |
| TRK-IN-16 | C19H20FN5O | 1365212-81-2 | Details |
| Antibacterial agent 97 | C19H23N5S | 1714961-61-1 | Details |
| CXCR4 antagonist 8 | C21H26N6 | 2304750-84-1 | Details |
| Anti-osteoporosis agent-1 | C20H19ClN2O2 | 2761577-50-6 | Details |
| D18 | C21H28N6 | 2230218-36-5 | Details |
| Pantothenate kinase-IN-1 | C21H25N5O | 1024168-48-6 | Details |
| NSC114126 | C22H20O4 | 24909-18-0 | Details |
| 5-HT6/5-HT2A receptor ligand-1 | C21H19FN2O2 | 2411088-07-6 | Details |
| PTG-0861 | C15H9F5N2O3 | 2494082-34-5 | Details |
| EP3 antagonist 3 | C21H18N2O4 | 1227827-88-4 | Details |
| 5-HT7 agonist 2 | C23H29N3O | 1206846-61-8 | Details |
| AChE/BChE/BACE-1-IN-1 | C19H21F3N2O | 1321361-13-0 | Details |
| LmCPB-IN-1 | C18H30N6O2 | 2151025-98-6 | Details |
| Cdc7-IN-14 | C18H20N4O2S | 2764866-21-7 | Details |
| 3-(3-Phenoxybenzyl)amino-β-carboline | C24H19N3O | 1327080-54-5 | Details |
| ARN1468 | C16H17F3N4O2 | 1381459-14-8 | Details |
| DNA-PK-IN-6 | C19H21N7O | 2711810-41-0 | Details |
| Product Total： Product Page： | ||||
| 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 | ||||